BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7857667)

  • 1. Molecular basis of human band-3 mutation associated with increased anion transport.
    Kay MM; Bosman G; Johnson RC; Poulin J; Lawrence C; Goodman J
    Exp Clin Immunogenet; 1994; 11(4):209-21. PubMed ID: 7857667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human erythroid band 3 "anion exchanger 1" is expressed in transformed lymphocytes.
    Kay MM; Vollard CH
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):945-52. PubMed ID: 8960772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of senescent cell antigen on old cells initiates IgG binding to a neoantigen.
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):131-53. PubMed ID: 8513271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane protein band 3 alteration associated with neurologic disease and tissue-reactive antibodies.
    Kay MM; Goodman J; Goodman S; Lawrence C
    Exp Clin Immunogenet; 1990; 7(3):181-99. PubMed ID: 2383405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Band 3 and its alterations in health and disease.
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):117-38. PubMed ID: 15095783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Band-3 polymers and aggregates, and hemoglobin precipitates in red cell aging.
    Kay MM; Bosman GJ; Johnson GJ; Beth AH
    Blood Cells; 1988; 14(1):275-95. PubMed ID: 2846095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis.
    Jenkins PB; Abou-Alfa GK; Dhermy D; Bursaux E; Féo C; Scarpa AL; Lux SE; Garbarz M; Forget BG; Gallagher PG
    J Clin Invest; 1996 Jan; 97(2):373-80. PubMed ID: 8567957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into tyrosine phosphorylation control of protein-protein association from the NMR structure of a band 3 peptide inhibitor bound to glyceraldehyde-3-phosphate dehydrogenase.
    Eisenmesser EZ; Post CB
    Biochemistry; 1998 Jan; 37(3):867-77. PubMed ID: 9454576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell aging: senescent cell antigen, band 3, and band 3 mutations associated with cellular dysfunction.
    Kay MM
    Prog Clin Biol Res; 1989; 319():199-217; discussion 218-23. PubMed ID: 2533686
    [No Abstract]   [Full Text] [Related]  

  • 10. Posttranslational modifications of brain and erythrocyte band 3 during aging and disease.
    Kay MM; Rapcsak SZ; Bosman GJ; Goodman JR
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):919-44. PubMed ID: 8960771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional role of arginine 901 at the C-terminus of the human anion transporter band 3 protein.
    Takazaki S; Abe Y; Kang D; Li C; Jin X; Ueda T; Hamasaki N
    J Biochem; 2006 May; 139(5):903-12. PubMed ID: 16751598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies on the effects of the deletion in the red cell anion exchanger (band 3, AE1) associated with South East Asian ovalocytosis.
    Chambers EJ; Bloomberg GB; Ring SM; Tanner MJ
    J Mol Biol; 1999 Jan; 285(3):1289-307. PubMed ID: 9887277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carboxyl side chain of glutamate 681 interacts with a chloride binding modifier site that allosterically modulates the dimeric conformational state of band 3 (AE1). Implications for the mechanism of anion/proton cotransport.
    Salhany JM; Sloan RL; Cordes KS
    Biochemistry; 2003 Feb; 42(6):1589-602. PubMed ID: 12578372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical labelling of arginyl-residues involved in anion transport mediated by human band 3 protein and some aspects of its location in the peptide chain.
    Zaki L; Böhm R; Merckel M
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):1053-63. PubMed ID: 8960780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of the human erythrocyte band 3 protein C-terminal domain.
    Fu G; Wang T; Yang B; Lv F; Shi C; Jiang X; Tian L; Yu W; Hamasaki N
    Biochemistry; 2004 Feb; 43(6):1633-8. PubMed ID: 14769040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local structural difference between human and bovine band 3 in the anion transport inhibitor-binding region.
    Moriyama R; Tomida M; Hoshino F; Makino S
    Int J Biochem Cell Biol; 1995 Jun; 27(6):575-83. PubMed ID: 7671135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport-related conformational states of the band 3 protein: probing with 1-fluoro-2,4-dinitrobenzene.
    Ruffing W; Gärtner EM; Lepke S; Legrum B; Passow H
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):1097-118. PubMed ID: 8960782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of the band 3 Cl-/HCO3- transporter in chronic respiratory failure patients.
    Yang X; Qian G; Mao B
    Chin Med J (Engl); 1996 Sep; 109(9):680-3. PubMed ID: 9275335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells.
    Bruce LJ; Wrong O; Toye AM; Young MT; Ogle G; Ismail Z; Sinha AK; McMaster P; Hwaihwanje I; Nash GB; Hart S; Lavu E; Palmer R; Othman A; Unwin RJ; Tanner MJ
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):41-51. PubMed ID: 10926824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Band 3 and its peptides during aging, radiation exposure, and Alzheimer's disease: alterations and self-recognition.
    Kay MM; Lake D; Cover C
    Adv Exp Med Biol; 1995; 383():167-93. PubMed ID: 8644501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.